Objective: While the most common cause of sudden cardiac arrest (SCA) in the general population is ischemic cardiac disease including acute myocardial infarction (AMI), previous preliminary data highlighted pulmonary embolism (PE) as a common cause of SCA among psychiatric patients. The aim of this study was to examine the proportion of patients with comorbid psychiatric disorders among patients hospitalized for either AMI or PE using a Japanese nationwide database.
Methods: This study used Diagnosis Procedure Combination (DPC) data between April 2013 and March 2018 provided by the Ministry of Health, Labor, and Welfare. The DPC data included information on the causes of hospitalization and comorbidities of psychiatric diseases among inpatients in all acute care hospitals in Japan. The proportions of patients with schizophrenia (ICD-10 code F20), mood disorders (F31 or F32), and no psychiatric disorders were analyzed among patients who were hospitalized for AMI and PE.
Results: The data from 351,159 AMI patients (mean age = 70.3 years) and 52,036 PE patients (mean age = 69.2 years) were used. Mortality rates were 8.0%–14.4% in AMI patients and 4.3%–9.8% in PE patients. The AMI group was predominantly male. The proportions of patients with schizophrenia and mood disorder were significantly higher in the PE group than in the AMI group (schizophrenia: 2.53% [1,314/52,036] vs 0.55% [1,922/351,159], P < .001; mood disorder: 2.94% [1,532/52,036] vs 0.60% [2,099/351,159], P < .001).
Conclusions: The results highlight the importance of PE as a major cause of SCA in this specific population and the need for preventive measures to mitigate the mortality gap among patients with psychiatric disorders.
Continue Reading...
Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Risgaard B, Waagstein K, Winkel BG, et al. Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: a nationwide cohort study from Denmark. J Clin Psychiatry. 2015;76(9):e1122–e1129. PubMedCrossRef
Ifteni P, Correll CU, Burtea V, et al. Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients. Schizophr Res. 2014;155(1–3):72–76. PubMedCrossRef
Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 2015;116(12):1887–1906. PubMedCrossRef
Ishida T, Miyazaki K, Yukawa T, et al. Etiology of out-of-hospital cardiac arrest in psychiatric patients: chart review. Psychiatry Clin Neurosci. 2019;73(5):243–247. PubMedCrossRef
Ishida T, Takahashi K, Sugiyama K, et al. How common is pulmonary embolism compared to acute myocardial infarction among patients with severe mental illnesses? Psychiatry Clin Neurosci. 2020;74(4):277–278. PubMedCrossRef
Ono Y, Taneda Y, Takeshima T, et al. Validity of claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese administrative database. Clin Epidemiol. 2020;12:367–375. PubMedCrossRef
Ando T, Ooba N, Mochizuki M, et al. Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center. BMC Health Serv Res. 2018;18(1):895. PubMedCrossRef
Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27(10):476–482. PubMedCrossRef
Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341(sep21 1):c4245. PubMedCrossRef
Parkin L, Balkwill A, Sweetland S, et al; Million Women Study Collaborators. Antidepressants, depression, and venous thromboembolism risk: large prospective study of UK women. J Am Heart Assoc. 2017;6(5):e005316. PubMedCrossRef
Plana-Ripoll O, Pedersen CB, Agerbo E, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet. 2019;394(10211):1827–1835. PubMedCrossRef
Heiberg IH, Nesvåg R, Balteskard L, et al. Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness. Acta Psychiatr Scand. 2020;141(5):439–451. PubMedCrossRef
Nielsen RE, Kugathasan P, Straszek S, et al. Why are somatic diseases in bipolar disorder insufficiently treated? Int J Bipolar Disord. 2019;7(1):12. PubMedCrossRef
Gureje O, Ustün TB, Simon GE. The syndrome of hypochondriasis: a cross-national study in primary care. Psychol Med. 1997;27(5):1001–1010. PubMedCrossRef
Hoirisch-Clapauch S, Nardi AE, Gris JC, et al. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? Thromb Res. 2014;134(1):11–16. PubMedCrossRef
Taylor CB, Youngblood ME, Catellier D, et al; ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62(7):792–798. PubMedCrossRef
Li H, Li J, Yu X, et al. The incidence rate of cancer in patients with schizophrenia: a meta-analysis of cohort studies. Schizophr Res. 2018;195:519–528. PubMedCrossRef
Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–1046. PubMedCrossRef
Penninx BWJH, Lange SMM. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73. PubMedCrossRef